LIPOSOMAL AMPHOTERICIN B (L-AMB) TWICE WEEKLY AS ANTIFUNGAL PROPHYLAXIS IN PEDIACTRIC CANCER PATIENTS

被引：0
|
作者：
Lehrnbecher, Thomas [1 ]
Schedler, Nadine [1 ]
Tramsen, Lars [1 ]
Becker, Martina [1 ]
Klingebiel, Thomas [1 ]
Bochennek, Konrad [1 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2010年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：948 / 949
页数：2
相关论文
共 50 条
  • [31] Safety of a weekly administration of 10 mg/kg of liposomal amphotericin B for antifungal prophylaxis in allogeneic stem-cell transplant and acute leukemia patients.
    Cordonnier, C
    Mohty, M
    Faucher, C
    Vey, N
    Pautas, C
    Robin, M
    Mahi, L
    Ribaud, P
    BLOOD, 2005, 106 (11) : 422B - 422B
  • [32] High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
    El-Cheikh, J.
    Faucher, C.
    Furst, S.
    Duran, S.
    Berger, P.
    Vey, N.
    Stoppa, A-M
    Bouabdallah, R.
    Gastaut, J-A
    Viens, P.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 (05) : 301 - 306
  • [33] High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
    J El-Cheikh
    C Faucher
    S Fürst
    S Duran
    P Berger
    N Vey
    A-M Stoppa
    R Bouabdallah
    J-A Gastaut
    P Viens
    D Blaise
    M Mohty
    Bone Marrow Transplantation, 2007, 39 : 301 - 306
  • [34] High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation
    El Cheikh, J.
    Faucher, C.
    Furst, S.
    Duran, S.
    Berger, P.
    Vey, N.
    Stoppa, A. M.
    Bouabdallah, R.
    Gastaut, J. A.
    Viens, P.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S164 - S164
  • [35] Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study
    Cordonnier, Catherine
    Mohty, Mohamad
    Faucher, Catherine
    Pautas, Cecile
    Robin, Marie
    Vey, Norbert
    Monchecourt, Francoise
    Mahi, Lamine
    Ribaud, Patricia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (02) : 135 - 141
  • [36] HIGH DOSE LIPOSOMAL AMPHOTERICIN B (HD-L-AMB) IN THE PROPHYLAXIS OF INVASIVE FUNGAL DISEASES (IFD) IN ADULT AND ELDERLY ACUTE LEUKEMIA (AL) PATIENTS (PTS)
    Anaclerico, B.
    Chierichini, A.
    Fenu, S.
    Cedrone, M.
    Bongarzoni, V.
    Ronci, B.
    Borza, P. Anticoli
    Cortese, S.
    Iacovino, P.
    Annino, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 362 - 362
  • [37] Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation
    Umemura, Keisuke
    Katada, Yoshiki
    Nakagawa, Shunsaku
    Hira, Daiki
    Yutaka, Yojiro
    Tanaka, Satona
    Ohsumi, Akihiro
    Nakajima, Daisuke
    Date, Hiroshi
    Nagao, Miki
    Terada, Tomohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (08) : 741 - 745
  • [38] High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient
    Brazzola, Pierluigi
    Rossi, Mario R.
    MEDICAL MYCOLOGY CASE REPORTS, 2014, 3 : 1 - 3
  • [39] Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients
    Eldem, T
    Arican-Cellat, N
    Agabeyoglu, I
    Akova, M
    Kansu, E
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 213 (1-2) : 153 - 161
  • [40] Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease
    Bochennek, K.
    Balan, A.
    Mueller-Scholden, L.
    Becker, M.
    Farowski, F.
    Mueller, C.
    Groll, A. H.
    Lehrnbecher, T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) : 1527 - 1530
12345